Guilford Pharmaceuticals to Announce First Quarter 2004 Financial Results on Monday, May 10, 2004

Guilford Pharmaceuticals to Announce First Quarter 2004 Financial
Results on Monday, May 10, 2004 


BALTIMORE, April 27  /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inc. 
will announce its first quarter 2004 financial results on Monday, May 10, 2004
before the opening of the U.S. financial markets.  The company will also host a
conference call and live audio webcast at 11:00 a.m. E.T. following the
announcement.  During this call, Guilford's management will discuss the
financial results and other business for the upcoming year.

The press release and live webcast can be accessed by going to the Investor
Relations section of Guilford's website at http://www.guilfordpharm.com/.
Following the webcast, an archived version of the call will be available until
Monday, May 17, 2004.

To participate in the live conference call, U.S. residents should dial
888-482-0024, international callers 617-801-9702.  The participant passcode is
90913233.

An audio replay of the conference call will be available for 72 hours beginning
at approximately 1:00 p.m. E.T. on May 10, 2004 through 1:00 p.m. May 13, 2004.
 To access the replay, U.S. residents should dial 888-286-8010, (int'l callers
617-801-6888), passcode 32350709.

Guilford Pharmaceuticals Inc. is a fully integrated pharmaceutical company
engaged in the research, development and commercialization of products that
target the hospital market.  Presently, Guilford markets two commercial
products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R)
Injection, a glycoprotein GP IIb/IIIa receptor antagonist used for the
treatment of acute coronary syndrome (ACS).  Guilford's product pipeline
includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating
Parkinson's disease and post-prostatectomy erectile dysfunction.

   Contact:    Guilford Pharmaceuticals Inc.
               Stacey Jurchison
               410.631.5022
               

DATASOURCE: Guilford Pharmaceuticals Inc.



CONTACT:  Stacey Jurchison, Guilford Pharmaceuticals Inc.,

[phone], 



Web site:  http://www.guilfordpharm.com/ 



Company News On-Call:  http://www.prnewswire.com/comp/112882.html

Copyright